Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation
Type
Blog Post
...therapeutic strategies.
Sarat Chandarlapaty (MSKCC) reported that APOBEC3-dominant breast tumors resist endocrine...